Skip to main content
Full access
Brief Reports
Published Online: 1 November 2017

Family Involvement in the Clinical Care of Clients With First-Episode Psychosis in the RAISE Connection Program

Abstract

Objective:

This study described how families were involved in the RAISE Connection Program for clients with first-episode psychosis (FEP) and examined factors that predicted family involvement.

Methods:

Presence of family members at clinical visits for 65 clients with FEP was described. Multiple regressions were conducted to determine whether demographic characteristics, clinical factors, or client-provider discussions regarding family predicted family involvement during the first six months of the program.

Results:

Most participants (95%) had at least one family member attend a clinical visit during program involvement. Age of the client with FEP, psychiatric symptoms, and substance use predicted the number of days family members attended visits during the first six months of program participation; client-provider discussions about family did not.

Conclusions:

Family involvement in the ongoing care of clients with FEP is common when efforts are made to engage clients with FEP and their families.
Families play a pivotal role in the recovery process of young people who have experienced first-episode psychosis (FEP). Families are usually the first to observe symptoms, initiate treatment, and support treatment involvement (13). These families, often distressed and facing uncertainty around prognosis and economic strain, are in desperate need of information and services.
Despite strong evidence for its effectiveness, participation in family psychoeducation offered through FEP treatment programs has been limited, with only younger age, greater symptoms, and substance use shown to predict involvement (4,5). Consumer and family needs and preferences regarding family services often play a role in participation in family psychoeducation. A shared decision-making approach that helps clients with FEP and families understand options and make decisions about involvement that best fit needs and preferences has produced significant increases in family involvement (6).
The Recovery After an Initial Schizophrenia Episode Implementation and Evaluation Study’s (RAISE IES’s) Connection Program is a team-based, multidisciplinary, and multielement treatment program that provides a range of services to clients with FEP and their families for up to two years (7). Connection Program team members (team leader, psychiatrist, recovery coach, and individual placement and support [IPS] specialist) offer an array of family-based approaches in addition to formal family psychoeducation. Guided by a shared decision-making framework, team members provide clients and families with information on ways families could be involved, explore needs and preferences regarding involvement, and help identify the type of involvement that best fits preferences and needs. Families can participate in a variety of services, including treatment planning, meetings with the psychiatrist, working with the IPS specialist around school or work supports, and utilizing specialized family services (such as multifamily psychoeducation groups) offered by the recovery coach. [A detailed program description is available in an online supplement to this report.]
This study described involvement of families of clients participating in RAISE IES’s Connection Program over time in terms of the frequency of visits and which visits were attended by family. We also examined whether demographic characteristics, clinical factors, and self-reported client-provider discussions about family involvement predicted family involvement during the first six months of program participation.

Methods

Sixty-five participants were enrolled in the RAISE IES study in Baltimore and New York City. Eligible persons were age 15–35 years; met DSM-IV criteria for schizophrenia, schizoaffective disorder, schizophreniform disorders, delusional disorder, or psychosis not otherwise specified; and had experienced psychotic symptoms for at least a week with onset in the past two years. Exclusion criteria included having a nonpsychiatric medical condition that impaired functioning, another diagnosis causing the psychosis, or mental retardation. Participants provided informed consent; for minors, the parent or guardian provided informed consent and the minor provided assent. The institutional review boards of the New York State Psychiatric Institute and the University of Maryland approved all study procedures.
Starting on July 1, 2011, trained clinical research interviewers completed standardized assessments at baseline and at six, 12, 18, and 24 months or until data collection ended on June 30, 2013. Participants who were enrolled after February 7, 2013, or who declined further participation had shorter follow-up periods. Clinical assessment and study participation details have been previously reported (7). The Positive and Negative Syndrome Scale (PANSS) (8) was used to assess symptoms; the Mental Illness Research, Education and Clinical Center Global Assessment of Functioning (MIRECC GAF) social and occupational functioning scales adapted for individuals with early psychosis were used to assess social and occupational functioning (9); and two items from the Addiction Severity Index (10) were used to assess alcohol or drug use. Chart reviews provided information on family participation in visits with each team member. Three items from the six-month assessment were used to assess the client’s experience of the treatment model focused on family involvement: In the previous month, “How often did providers talk with you about how family could help support you in reaching your goals?” “How often did providers talk with you about how you would like family/supportive others to be involved in your treatment?” and “How often did providers help you talk with family about your thoughts and feelings?” Possible responses were 1, not at all; 2, a little; 3, a moderate amount; and 4, a lot.
Percentages and means were calculated to describe family visit attendance with each team member and overall and the percentage of clients whose family attended at least one visit for each three-month quarter of program participation (for example, quarter 1, months 1–3 of the participant’s involvement; quarter 2, months 4–6 of the participant’s involvement) was determined. A multiple regression that included age, gender, baseline clinical characteristics, and illness severity (20-item PANSS total score) (11), substance use (presence or absence), inpatient hospitalization within six months of baseline (illness severity marker), and functioning (MIRECC GAF scores) as independent variables was conducted to assess predictors of days of family visits during the first six months of program participation. Analysis was limited to the first six months because of drop-off in the number of participants (due to study termination). A separate regression model was used to assess whether clients’ report of client-provider discussions regarding family and family involvement was related to the number of days of family visits during the first six months of program participation.

Results

A total of 41 (63%) participants were male; 24 (37%) were female. Most had a diagnosis of schizophrenia (N=43, 66%). The mean±SD age of participants was 22.2±4.2 years. Eight participants were younger than age 18 years. A total of 28 (43%) identified themselves as black, 25 (39%) as white, 4 (6%) as Asian/Pacific Islander, and 8 (13%) as a member of other groups or did not specify a group. Most participants were living with family (N=49, 76%). Almost all participants (N=62, 95%) had a family member who had contact with the Connection team during program involvement; a majority had multiple contacts. Table 1 shows data on attendance by family members during visits with various team members and the visit pattern over time.
TABLE 1. Clients in the RAISE Connection Program whose family members attended visits to various members of the provider team over the 24-month course of the program
 Over the course of the program (N=65)Quarter 1 (N=63)Quarter 2 (N=60)Quarter 3 (N=53)Quarter 4 (N=50)Quarter 5 (N=42)Quarter 6 (N=32)Quarter 7 (N=21)Quarter 8 (N=6)
Team memberN%N%N%N%N%N%N%N%N%
All team members                  
 Any family member attendance62955181345727513162215014441152467
 N of visits                  
  M±SD10.2±10.9 3.6±3.6 1.9±2.4 1.5±2.4 1.5±1.9 1.3±1.9 1.4±1.8 1.0±1.3 .8±.8 
  Range0–62 0–15 0–11 0–11 0–8 0–9 0–6 0–5 0–2 
Team leader                  
 Any family member attendance6194487629481936214217411341629350
 N of visits                  
  M±SD6.4±7.2 2.6±2.9 1.2±1.6 .8±1.5 .9±1.5 .8±1.3 .8±1.1 .4±.7 .7±.8 
  Range0–43 0–13 0–8 0–7 0–7 0–5 0–3 0–2 0–2 
Supported employment or education specialist                  
 Any family member attendance467133521728142616321229722524117
 N of visits                  
  M±SD4.2±7.1 1.5±2.4 .7±1.5 .7±1.8 .7±1.4 .4±.7 .5±1.2 .2±.4 .2±.4 
  Range0–44 0–12 0–8 0–9 0–7 0–3 0–5 0–1 0–1 
Psychiatrist                  
 Any family member attendance5788375922372140214217411031733350
 N of visits                  
  M±SD6.4±8.9 1.6±2.1 .9±1.7 1.0±1.7 .9±1.4 .7±1.3 .8±1.4 .5±.8 .5±.6 
  Range0–52 0–11 0–8 0–8 0–6 0–6 0–4 0–3 0–1 
Recovery coach                  
 Any family member attendance5178436827452038193815361238733233
 N of visits                  
  M±SD5.3±7.0 2.6±3.3 1.2±1.8 1.0±2.0 .9±1.5 .6±.9 .8±1.4 .5±.9 .3±.5 
  Range0–38 0–13 0–8 0–9 0–7 0–3 0–6 0–4 0–1 
Multivariate analyses showed that age (β=.66, t=−4.97, df=1, p<.001), symptom severity (β=.21, t=2.15, df=1, p=.036), and substance use (β=−.28, t=−3.02, df=1, p=.004) predicted number of family visit days during the first six months of the program. [Further details about the analyses are available in the online supplement to this report.] Participants younger than age 18 years, with greater symptom severity, and with no substance use had more family visit days. This model explained 59% of the variance (F=11.12, df=7 and 54, p<.001).
The mean response for frequency of client-provider conversations around how family could support goals, how clients would like family to be involved in treatment, and helping clients talk with family about thoughts/feelings was between “a little” and “a moderate amount” for all three questions (2.59±1.14; 2.63±1.07; 2.91±1.07, respectively). Increased self-reported discussions of family involvement did not predict the number of days family members were present at visits with a team member during the first six months (F=.92, df=3 and 52, p=.44).

Discussion

Almost all of the study participants with FEP had a family member involved in the program at some point during their care, with many having family contact with multiple team members. Although it is not surprising that most contact was with the team leader and the psychiatrist, given their roles, families had substantial contact with other team members, suggesting that families were interested in an array of care components. This may be due to the program’s shared decision-making approach to services, which allows providers to educate clients and family members concerning ways family can be involved and how involvement can support recovery and which ensures access and opportunities to work with a variety of team members.
Family member involvement occurred more frequently during the first quarter of the program. Greater involvement in instances of acute distress or during service transitions has been shown to be common, because of the greater need for information, guidance, and support (12). Declines in family presence at visits after the first quarter may reflect less perceived need for services later in care. Despite the decline, family involvement remained substantial over the course of the program. One key element of the program was creating a family friendly environment, with ongoing family outreach via phone, home visits, and mailings; inclusion efforts; and collaborative decision making around ways to address client and family needs. Qualitative interviews conducted with clients and family members indicated that ongoing, active outreach and support and tailoring of the program and services to client and family needs helped both clients and families engage with and stay connected to the program, likely contributing to ongoing family involvement (3,13).
Consistent with previous research (4,5), we found that clients’ being younger (younger than age 18 years) and having more psychiatric symptoms predicted greater family involvement during the first six months of the program. Because youths younger than age 18 years require a family member or guardian for care decisions, it is not surprising their families had more contact. However, the benefits of the outreach and engagement efforts, as well as working collaboratively with clients and families to identify recovery goals and ways family can support those goals, are just as important when working with younger clients. Less family involvement among young adults age 18 years and older may reflect less perceived need for family involvement. Alternatively, concerns about privacy, family burden, or loss of autonomy and independence may lead young people to struggle more with decisions around involving family (12). Similarly, family members may have reservations about involvement, due to limited knowledge, respect for the client’s privacy and autonomy, and time constraints (3). Potential barriers such as these highlight the importance of engaging clients with FEP and their families in discussions about the benefits of involvement and addressing any concerns that might prevent family participation.
More frequent family involvement among clients with greater symptoms may reflect greater perceived family need. Greater psychiatric symptoms exhibited by a client with FEP can lead to family distress and perceived burden (14), which, in turn, may lead to greater family involvement. Less family participation among those with substance use may reflect less interest on the part of the client in including family, especially if substance use is a source of disagreement, or less client participation in services, limiting opportunities for family involvement.
Client-provider conversations around family involvement and support were common, with most participants indicating these occurred to some extent during the previous month. However, client-provider conversations about family or family involvement did not predict family attendance at visits. Information on client-provider conversations was collected only for the month prior to the assessment, rather than over the full six months of initial program participation. Although responses suggest that conversations frequently occurred, whether they occurred consistently throughout participation and their potential impact on family involvement are unknown. Participation in family meetings was shown to mediate improvements in social functioning among individuals in the Connection Program (15). Future work is needed to determine whether regular discussions about family involvement are associated with family participation over time.

Conclusions

Family involvement in the ongoing care of clients with FEP is common, especially when active, ongoing efforts are made to engage clients with FEP and their families. Younger age, greater symptoms, and lack of substance use prior to entering the program predicted family attendance at program visits; client-provider discussions regarding family or family involvement in the month prior to the six-month assessment did not predict family attendance. Additional research is needed to determine whether regular, ongoing discussions are associated with family participation over time.

Supplementary Material

File (appi.ps.201700080.ds001.pdf)

References

1.
Norman RM, Malla AK, Manchanda R: Delay in treatment for psychosis: its relation to family history. Social Psychiatry and Psychiatric Epidemiology 42:507–512, 2007
2.
O’Callaghan E, Turner N, Renwick L, et al: First episode psychosis and the trail to secondary care: help-seeking and health-system delays. Social Psychiatry and Psychiatric Epidemiology 45:381–391, 2010
3.
Lucksted A, Stevenson J, Nossel I, et al: Family member engagement with early psychosis specialty care. Early Intervention in Psychiatry, 2016 (
4.
Jeppesen P, Petersen L, Thorup A, et al: Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial. British Journal of Psychiatry 48:s85–s90, 2005
5.
Fjell A, Bloch Thorsen GR, Friis S, et al: Multifamily group treatment in a program for patients with first-episode psychosis: experiences from the TIPS project. Psychiatric Services 58:171–173, 2007
6.
Dixon LB, Glynn SM, Cohen AN, et al: Outcomes of a brief program, REORDER, to promote consumer recovery and family involvement in care. Psychiatric Services 65:116–120, 2014
7.
Dixon LB, Goldman HH, Bennett ME, et al: Implementing coordinated specialty care for early psychosis: the RAISE Connection Program. Psychiatric Services 66:691–698, 2015
8.
Opler LA, Kay S, Lindenmayer JP, et al: Structured Clinical Interview for the Positive and Negative Syndrome Scale. New York, Multi-Health Systems, 1992
9.
Niv N, Cohen AN, Sullivan G, et al: The MIRECC version of the Global Assessment of Functioning scale: reliability and validity. Psychiatric Services 58:529–535, 2007
10.
Leonhard C, Mulvey K, Gastfriend DR, et al: The Addiction Severity Index: a field study of internal consistency and validity. Journal of Substance Abuse Treatment 18:129–135, 2000
11.
Stefanovics EA, Elkis H, Zhening L, et al: A cross-national factor analytic comparison of three models of PANSS symptoms in schizophrenia. Psychiatry Research 219:283–289, 2014
12.
Drapalski AL, Marshall T, Seybolt D, et al: Unmet needs of families of adults with mental illness and preferences regarding family services. Psychiatric Services 59:655–662, 2008
13.
Lucksted A, Essock SM, Stevenson J, et al: Client views of engagement in the RAISE Connection Program for early psychosis recovery. Psychiatric Services 66:699–704, 2015
14.
Addington J, Coldham EL, Jones B, et al: The first episode of psychosis: the experience of relatives. Acta Psychiatrica Scandinavica 108:285–289, 2003
15.
Marino L, Nossel I, Choi JC, et al: The RAISE Connection Program for early psychosis: secondary outcomes and mediators and moderators of improvement. Journal of Nervous and Mental Disease 203:365–371, 2015

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Flying Geese, by Felix Bracquemond, 19th century. Black chalk, brush, and watercolor, highlighted with white gouache. Museum purchase, Davis Museum, Welleseley College. Photo credit: Davis Museum/Art Resource, New York City.

Psychiatric Services
Pages: 358 - 361
PubMed: 29089013

History

Received: 16 February 2017
Revision received: 15 July 2017
Accepted: 18 August 2017
Published online: 1 November 2017
Published in print: March 01, 2018

Keywords

  1. Young adults with CMI
  2. Families of the mentally ill
  3. First episode psychosis
  4. Family Involvement
  5. Early intervention

Authors

Details

Amy L. Drapalski, Ph.D. [email protected]
Dr. Drapalski is with the U.S. Department of Veterans Affairs (VA) Capital (VISN 5) Health Care Network, VA Maryland Health Care System, Baltimore. She is also with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore, where Dr. Medoff is affiliated. Ms. Piscitelli and Dr. Dixon are with the New York State Psychiatric Institute, and Dr. Dixon is also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, both in New York. Ms. Lee is with the Hunter College Lois V. and Samuel J. Silberman School of Social Work, New York.
Sarah Piscitelli, M.A.
Dr. Drapalski is with the U.S. Department of Veterans Affairs (VA) Capital (VISN 5) Health Care Network, VA Maryland Health Care System, Baltimore. She is also with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore, where Dr. Medoff is affiliated. Ms. Piscitelli and Dr. Dixon are with the New York State Psychiatric Institute, and Dr. Dixon is also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, both in New York. Ms. Lee is with the Hunter College Lois V. and Samuel J. Silberman School of Social Work, New York.
Rufina J. Lee, M.S.W.
Dr. Drapalski is with the U.S. Department of Veterans Affairs (VA) Capital (VISN 5) Health Care Network, VA Maryland Health Care System, Baltimore. She is also with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore, where Dr. Medoff is affiliated. Ms. Piscitelli and Dr. Dixon are with the New York State Psychiatric Institute, and Dr. Dixon is also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, both in New York. Ms. Lee is with the Hunter College Lois V. and Samuel J. Silberman School of Social Work, New York.
Deborah Medoff, Ph.D.
Dr. Drapalski is with the U.S. Department of Veterans Affairs (VA) Capital (VISN 5) Health Care Network, VA Maryland Health Care System, Baltimore. She is also with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore, where Dr. Medoff is affiliated. Ms. Piscitelli and Dr. Dixon are with the New York State Psychiatric Institute, and Dr. Dixon is also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, both in New York. Ms. Lee is with the Hunter College Lois V. and Samuel J. Silberman School of Social Work, New York.
Lisa B. Dixon, M.D., M.P.H.
Dr. Drapalski is with the U.S. Department of Veterans Affairs (VA) Capital (VISN 5) Health Care Network, VA Maryland Health Care System, Baltimore. She is also with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore, where Dr. Medoff is affiliated. Ms. Piscitelli and Dr. Dixon are with the New York State Psychiatric Institute, and Dr. Dixon is also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, both in New York. Ms. Lee is with the Hunter College Lois V. and Samuel J. Silberman School of Social Work, New York.

Notes

Send correspondence to Dr. Drapalski (e-mail: [email protected]).

Competing Interests

Ms. Lee and Dr. Dixon are offering training and consultation to help others provide the type of first-episode psychosis services described here. They do not expect to receive compensation for this training other than that received as part of work done for their employers. The authors report no financial relationships with commercial interests.

Funding Information

Maryland Mental Hygiene Administration
American Recovery and Reinvestment Act of 2009
Ministry of Science and technology of China: 2016YFC1306500
National Institute of Mental Health10.13039/100000025: #HHSN271209900020C
New York State Office of Mental Health10.13039/100004866
This project was funded in part with federal funds from the American Recovery and Reinvestment Act of 2009 and from the National Institute of Mental Health under contract HHSN271200900020C (Dr. Dixon, principal investigator) and with funds from the New York State Office of Mental Health and the Maryland Mental Hygiene Administration.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share